Relationship Between Artificial Oxytocin (Pitocin) Use At Birth For Labor Induction Or Augmentation

This is the complete text of the author's doctoral dissertation. The use of artificial oxytocin (Pitocin) at birth to initiate or augment labor has become commonplace in a vast number of American hospitals, where 99% of women give birth, with around two-thirds of inductions now being for non-medical reasons, yet little research to date has explored the possibility of enduring effects of such an intervention on children born with the use of this medication. This study attempted to answer the question, "What is the relationship between the use of artificial oxytocin at birth and the psychosocial functioning of the children at age 3?" It was hypothesized that artificial oxytocin use at birth contributes to an enduring imprint, revealed in the psychosocial functioning of young children. The sample comprised 514 mothers of vaginally-born 3-year-olds who were exposed (N = 231) or not exposed (N = 267) to artificial oxytocin at birth. Mothers responded to an online self-report survey about the hospital birth of these children, their development, and their current psychosocial functioning. Responses from mothers who received Pitocin at birth were compared to those of mothers who gave birth without Pitocin. The findings, analyses, and their interpretations are described and discussed, together with implications for parents and their children, and for research and future obstetrical practice.